Activities
2023
Short course on stakeholder engagement for academics 2023W. Boon (Organiser)
Jan 2023 → Feb 2023
2022
NWO and Jong-MVI early career after summer school on interdisciplinarityWouter Boon (Organiser)
6 Oct 2022 → 7 Oct 2022
Responsible Quantitative MRIWouter Boon (Invited speaker)
23 Sept 2022
, ResQuMRI presentatie en discussie in MRI klankbordgroepResponsible Quantitative MRIWouter Boon (Invited speaker)
15 Sept 2022
, ResQuMRI Co-creatie Workshop (stakeholders)EU-SPRI Conference 2022Wouter Boon (Organiser)
1 Jun 2022 → 3 Jun 2022
Short course on stakeholder engagement for academics 2022W. Boon (Organiser)
May 2022 → Jun 2022
Sustainability Transitions Research Network (External organisation)Wouter Boon (Member)
2022
2021
UU Open Science Public Engagement initiatief (External organisation)Wouter Boon (Member)
1 Sept 2021 → 31 Dec 2021
ZonMw beoordelingscommissie Innovative Medical Devices Initiative call demonstratieprojecten (External organisation)Wouter Boon (Member)
2021
Sustainability Transitions Research Network (External organisation)Wouter Boon (Member)
2021
Programmaraad, programma Maatschappelijk Verantwoord Innoveren (External organisation)Wouter Boon (Member)
2021
2020
Bedside production van geneesmiddelenW.P.C. Boon (Invited speaker)
24 Nov 2020
, Life Science - COVID-19 Online Kennisweek2019
Innovation in distributed forms of drug manufacturing: the case of in-hospital production of medicinesW.P.C. Boon (Presenter)
13 Dec 2019
, Annual International Workshop on Medical Innovation (WOMI) 2019The 17th International Open and User Innovation (OUI)ConferenceW.P.C. Boon (Organiser)
8 Jul 2019 → 10 Jul 2019
, The 17th International Open and User Innovation (OUI) Conference35th EGOS ColloquiumW.P.C. Boon (Chair)
4 Jul 2019 → 6 Jul 2019
A stakeholder workshop on the future of carsharing W.P.C. Boon (Organiser)
Jun 2019
Early-career symposium on Responsible Research and Innovation: Jong-MVI SymposiumW.P.C. Boon (Organiser)
8 Apr 2019
NWO – Dutch Research Council, committee of NWA-ORC 2019 (Dutch Research Agenda - Research along routes by Consortia)(External organisation)W.P.C. Boon (Member)
2019
2018
Demand-initiated distributed drug manufacturingW.P.C. Boon (Speaker)
12 Dec 2018 → 14 Dec 2018
, Annual International Workshop on Medical Innovation (WOMI)Regulatory Science Network Netherlands (External organisation)W.P.C. Boon (Member)
1 Oct 2018
The 16th annual international open and user innovation conferenceW.P.C. Boon (Organiser)
6 Aug 2018 → 8 Aug 2018
RSSN Workshop ‘What’s in, what’s out, what’s relevant? – Towards a sensible label’W.P.C. Boon (Organiser)
20 Jun 2018
Towards distributed drug innovationW.P.C. Boon (Speaker)
14 Jun 2018 → 16 Jun 2018
, 7th STS Italia Conference EU-SPRI 2018W.P.C. Boon (Member of programme committee)
6 Jun 2018 → 8 Jun 2018
The disruption of private car use – moving from ownership to access. Insights from the Dutch lease marketW.P.C. Boon (Speaker)
Jun 2018
, 5th International Workshop on the Sharing EconomyThe Disruption of the B2B model of an incumbent industry – Explaining private car lease strategiesW.P.C. Boon (Speaker)
Mar 2018
, 3rd NEST Conference "New Frontiers in Sustainability TransitionsConference NWO-MVI 'Connecting practices'W.P.C. Boon (Organiser)
19 Jan 2018
Supervisory committee Rathenau Institute report on ‘Living labs’ (External organisation)W.P.C. Boon (Member)
2018 → 2020
2017
The growing opportunity for and necessity for producing drugs at the bedsideW.P.C. Boon (Invited speaker)
Nov 2017
, MIT Innovation Lab MeetingAdvies bij beleidstraject versnellingsmakelaars eHealthW.P.C. Boon (Advisor)
16 Oct 2017 → 15 Mar 2018
Workshop ‘Beyond the current clinical endpoints, Regulatory Science Network NederlandW.P.C. Boon (Organiser)
6 Jul 2017
The 8th International Sustainability Transitions ConferenceW.P.C. Boon (Organiser)
18 Jun 2017 → 21 Jun 2017
Demand, challenges and innovation - Making sense of demand in challenge-based innovation policyW.P.C. Boon (Invited speaker)
Apr 2017
, International workshop on ‘Transforming innovation policy’UZelf (External organisation)W.P.C. Boon (Chair)
2017
Regulatory Science Network Nederland (External organisation)W.P.C. Boon (Chair)
2017
Regulatory Science Network Nederland (External organisation)W.P.C. Boon (Member)
2017
2016
Regulatory Science Network Netherlands Workshop 2018W.P.C. Boon (Chair)
20 Jun 2016
, Regulatory Science Network Netherlands Workshop 20182016 Eu-SPRI Annual Conference, “Exploring New Avenues for Innovation and Research Policies”, Lund, SwedenWouter Boon (Chair)
9 Jun 2016
Conditional access to pharmaceutical productsW.P.C. Boon (Invited speaker)
May 2016
, International workshop ‘Nice to meet? Meeting unmet medical needs: Intermediary user innovations – Internal versus external strugglesW.P.C. Boon (Invited speaker)
Mar 2016
, TRIPOD Research seminar on intermediariesYoung MVI (External organisation)W.P.C. Boon (Chair)
2016 → …
Regulatory Science Network Nederland (External organisation)W.P.C. Boon (Chair)
2016
2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden (Event)W.P.C. Boon (Member)
2016
, 2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden2015
WTMC Dissertation Day (2015)Wouter Boon (Participant)
26 Nov 2015
Opening innovation processes – the role of users. Invited presenter at Seminar ‘Just what is “open” about open societies?’ of the Utrecht University strategic theme ‘Institutions’ (2015)Wouter Boon (Invited speaker)
14 Sept 2015
International Sustainability Transitions ConferenceWouter Boon (Invited speaker)
26 Aug 2015 → 28 Aug 2015
International Open and User Innovation Conference Wouter Boon (Invited speaker)
13 Jul 2015 → 15 Jul 2015
International Open and User Innovation Conference Wouter Boon (Invited speaker)
13 Jul 2015 → 15 Jul 2015
The missing links. Demand based policy making and instruments in the context of mission orientation. Presentation at Eu-SPRI Conference, HelsinkiWouter Boon (Invited speaker)
10 Jun 2015 → 12 Jun 2015
, EU-SPRI Conference 2015Intermediation for eco-innovations: Aalto Centre for Entrepreneurship in the context of a university innovation ecosystem. Presentation at Eu-SPRI Conference, HelsinkiWouter Boon (Invited speaker)
10 Jun 2015 → 12 Jun 2015
, EU-SPRI Conference 2015Eu-SPRI ConferenceWouter Boon (Chair)
10 Jun 2015 → 12 Jun 2015
Dealing with conflicting demands in emerging technologies when public and private users collide. Presentation at Eu-SPRI Conference, HelsinkiWouter Boon (Invited speaker)
10 Jun 2015 → 12 Jun 2015
, EU-SPRI Conference 2015 First International Workshop on the Sharing Economy, UtrechtWouter Boon (Invited speaker)
4 Jun 2015 → 5 Jun 2015
First International Workshop on the Sharing Economy, UtrechtWouter Boon (Member of programme committee)
4 Jun 2015 → 5 Jun 2015
Co-creation of knowledge: Knowledge for Climate. Invited presentation at RRI Tools Conference, Lisbon, PortugalWouter Boon (Invited speaker)
14 Apr 2015
, RRI Tools ConferenceCo-creation to address grand societal challenges. Seminar series of the Manchester Business School, Manchester Institute of Innovation Research, Manchester, UKWouter Boon (Invited speaker)
Apr 2015
Conditional regulation of orphan drugs. Invited presentation at Seminar on innovating in the field of orphan drugs organised by the Dutch representative organisation of biotechnology companies HollandBio (2015)Wouter Boon (Invited speaker)
16 Mar 2015
Regulatory Science Network Nederland (External organisation)W.P.C. Boon (Chair)
2015
2014
International Conference on Future-Oriented Technology Analysis, Brussel)Wouter Boon (Invited speaker)
27 Nov 2014 → 28 Nov 2014
International workshop ‘Organisation of research programmes on climate change’ Wouter Boon (Invited speaker)
23 Sept 2014
Use of the conditional marketing authorisation pathway for oncology medicines, invited speaker at The Organisation for Professionals in Regulatory Affairs (TOPRA), Workshop on improving efficiency within the current regulatory system, Brussels, Belgium
Wouter Boon (Invited speaker)18 Sept 2014
Feitenkaart Geneesmiddelenonderzoek 2014, invited presentation at Dutch innovative pharmaceutical companies NefarmaWouter Boon (Invited speaker)
2 Sept 2014
Use of the conditional marketing authorisation pathway for oncology medicines, invited speaker European Federal Association for Pharmaceutical Industry & Association (EFPIA), BrusselsWouter Boon (Invited speaker)
Sept 2014
EASST 2014 ConferenceWouter Boon (Organiser)
Sept 2014
Use of the conditional marketing authorisation pathway for oncology products, presentation for EU-DG Sanco meetingWouter Boon (Invited speaker)
26 Aug 2014
, EU-DG Sanco meeting International Sustainability Transitions ConferenceWouter Boon (Invited speaker)
26 Aug 2014 → 29 Aug 2014
Invited presentation at European Medicines Agency, meeting on ‘Towards a learning regulatory system: how to address current regulatory challenges’, London, UK
Wouter Boon (Invited speaker)Jun 2014
Diffusion of user innovation – case of off-label drugs, presentation at 2014 EU-SPRI Annual Conference, Manchester, UKWouter Boon (Invited speaker)
Jun 2014
, 2014 Eu-SPRI Annual Conference2014 Eu-SPRI Annual ConferenceWouter Boon (Organiser)
Jun 2014
Use of the conditional marketing authorisation pathway for oncology products”, speaker at the TI Pharma/Escher stakeholder workshop “Towards a Learning System: How to Address Current Regulatory Challenges?”Wouter Boon (Invited speaker)
13 May 2014
, TI Pharma/Escher stakeholder workshop “Towards a Learning System: How to Address Current Regulatory Challenges?”Kenniscoproductie voor de grote maatschappelijke vraagstukken, invited lecture on knowledge co-production at the Ministry of infrastructure and the Environment
Wouter Boon (Invited speaker)23 Jan 2014
Invited speaker during eminar on ‘Drugs in drinking water’ as part of a project together with KWR Water research, UMC Utrecht, TU DelftWouter Boon (Invited speaker)
2014
, Seminar on ‘Drugs in drinking water’ as part of a project together with KWR Water research, UMC Utrecht, TU DelftInvited presentation at Top Institute Pharma Annual Research Day 2014Wouter Boon (Invited speaker)
2014
2013
Learning to shield Regulatory learning in sociotechnical tranistionsWouter Boon (Invited speaker)
26 Nov 2013
, Presentation at the Workshop "Constructing and contesting spaces for low-carbon energy innovation"Demand articulation in large-scale R&D programsWouter Boon (Invited speaker)
2013
, Invited speaker at Workshop Promisomics2010
Tentative positions: The positioning of intermediary organisations in the context of emerging technologiesWouter Boon (Invited speaker)
28 Oct 2010
, Paper presented at the international conference Tentative Governance in Emerging Science and TechnologyNew Modes of Governing Pharmacovigilance: A contribution to responsible innovationWouter Boon (Invited speaker)
28 Oct 2010
, Presentation for International Conference Tentative GovernanceDemand articulation in emerging technologies: the role of Intermediary user organizationsWouter Boon (Invited speaker)
19 Aug 2010
, Presentation at Helsinki Collegium for Advanced Studies, University of Helsinki. The role of users in teh intertwined changes of technology and practice (Helsinki, Finland)Presentation at the 19th Society for Risk Analysis (SRA)- Europe conference: Risk, Governance & AccountabilityWouter Boon (Invited speaker)
21 Jun 2010
, Presentation at the 19th Society for Risk Analysis (SRA) - Europe conference: Risk, Governance & AccountabilityNew modes of governing pharmacovigilance for genomics-based drugsWouter Boon (Invited speaker)
27 May 2010
, Presentation at the 3rd International Conference Ten years after - Mapping the societal landscape of genomics - applying for the Urban zonePositioning intermediary organisations in innovationWouter Boon (Invited speaker)
26 May 2010
, Paper presented at Wageningen International Conference on Chain and Network Management2009
Shared Value Development towards a Metropolitan AgricultureWouter Boon (Invited speaker)
4 Jun 2009
, Proceedings of the KSI conference on "Dynamics and Governance of Transitions to Sustainability"2008
Demand articulation in emerging technologies: Intermediary user organizations as loci for multiple stakeholder FTA?Wouter Boon (Invited speaker)
16 Oct 2008
, Presentation at 3rd International Seville conference on Future-oriented Technology Analysis (FTA) Impacts and implications for policy and decisions makingDemand articulation in emerging genomics technologies: the role of patient organizationsWouter Boon (Invited speaker)
1 Oct 2008
, Abstract/paper for FTA ConferenceDemand articulation in emerging genomics technologies: the role of patient organisationsWouter Boon (Invited speaker)
20 Aug 2008
, Presentation at 4S/EASST Conference Acting with science, technology and medicineDemand articulation in emerging genomics technologies: the role of patient organisationsWouter Boon (Invited speaker)
17 Apr 2008
, Presentation at CSG Society & Genomics ConferenceBelangenbehartiging door patientenorganisaties - de discussie over dure geneesmiddelenWouter Boon (Invited speaker)
2008
, NFK&U2007
Patient advocacy and incomplete emerging pharmaceutical technologiesWouter Boon (Invited speaker)
19 Sept 2007
, Conference on pharmaceutical policy analysisDemand articulation in emerging technologies - a case of an intermediary organisationWouter Boon (Invited speaker)
24 Jun 2007
, Sixth annual meeting of the Technology, Management and Policy graduate consortiumDemand articulation in pharmacogenomics innovations - a case of an intermediary organisationWouter Boon (Invited speaker)
26 Mar 2007
, Cesagen&CSG Genomics and Society conferenceOnderzoeksschool Wetenschap (External organisation)Wouter Boon (Member)
2007
2005
Genomics and society: Chances for true love?Wouter Boon (Participant)
16 Dec 2005
Corsage workshop Genomics and society: chances for true love?Wouter Boon (Invited speaker)
16 Dec 2005
Identifying innovation hot spots in nutrigenomicsWouter Boon (Invited speaker)
1 Sept 2005
, NUGO conferenceUser-producer interactions in functional genomics innovationsWouter Boon (Invited speaker)
23 Feb 2005
, INNOGEN International Conference on Evolution of the Life Science Industries